WMSA
BLFS icon

Weiss Multi-Strategy Advisers’s BioLife Solutions BLFS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,000
Closed -$241K – 515
2018
Q4 		$241K Buy
+20,000
New +$239K 0.01% 402

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BLFS Position: Q1 2019 in Review

Weiss Multi-Strategy Advisers sold out of BioLife Solutions (BLFS) in Q1 2019, closing a stake of 20,000 shares — an estimated $241K sold.

Weiss Multi-Strategy Advisers first reported a position in BLFS in Q4 2018 and held it in 1 quarter. The position peaked at $241K in Q4 2018. 66 funds tracked by Wall St. Rank hold BLFS as of Q1 2019.

  • Weiss Multi-Strategy Advisers reported no remaining BioLife Solutions position as of Q1 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 20,000 BioLife Solutions shares in Q1 2019, an estimated $241K.
  • Weiss Multi-Strategy Advisers first reported a position in BioLife Solutions in Q4 2018 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's BioLife Solutions position peaked at $241K in Q4 2018.
  • 66 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.